These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 6964032
41. Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia. Komp DM, George SL, Falletta J, Land VJ, Starling KA, Humphrey GB, Lowman J. Cancer; 1976 Mar; 37(3):1243-7. PubMed ID: 1063049 [Abstract] [Full Text] [Related]
42. Acute tumor lysis syndrome in prolymphocytic leukemia. Gomez GA, Han T. Arch Intern Med; 1987 Feb; 147(2):375-6. PubMed ID: 3468888 [Abstract] [Full Text] [Related]
43. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. Garay G, Milone J, Dibar E, Pavlovsky S, Kvicala R, Sackmann Muriel F, Montres Varela D, Eppinger-Helft M. Cancer Chemother Pharmacol; 1983 Feb; 10(3):224-6. PubMed ID: 6345018 [Abstract] [Full Text] [Related]
44. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia. Park CH, Amare M, Morrison FS, Maloney TR, Goodwin JW. Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232 [Abstract] [Full Text] [Related]
47. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, Salim MF, Osman M, Osman L, El-Solh H. Cancer; 2003 Jun 01; 97(11):2898-903. PubMed ID: 12767105 [Abstract] [Full Text] [Related]
48. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model. Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM. Clin Cancer Res; 2000 Dec 01; 6(12):4950-6. PubMed ID: 11156256 [Abstract] [Full Text] [Related]
49. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network. Hainsworth JD, Litchy S, Morrissey LH, Andrews MB, Grimaldi M, McCarty M, Greco FA. J Clin Oncol; 2005 Mar 01; 23(7):1500-6. PubMed ID: 15632411 [Abstract] [Full Text] [Related]
50. Prognostic and therapeutic advances in CLL management: the experience of the French Cooperative Group. French Cooperative Group on Chronic Lymphocytic Leukemia. Semin Hematol; 1987 Oct 01; 24(4):275-90. PubMed ID: 3317854 [No Abstract] [Full Text] [Related]
51. Remission induction with daunomycin, vincristine, and prednisone in adult acute lymphocytic leukemia. Einhorn LH, Bond WH. Oncology; 1977 Oct 01; 34(1):25-8. PubMed ID: 266674 [Abstract] [Full Text] [Related]
52. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators. Holland JF, Ohnuma T. Cancer Treat Rep; 1981 Oct 01; 65 Suppl 4():123-30. PubMed ID: 7049376 [Abstract] [Full Text] [Related]
53. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL. Federico M, Clò V, Brugiatelli M, Carotenuto M, Gobbi PG, Vallisa D, Lombardo M, Avanzini P, Di Renzo N, Dini D, Baldini L, Silingardi V. Haematologica; 1998 Sep 01; 83(9):800-11. PubMed ID: 9825577 [Abstract] [Full Text] [Related]
54. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone. Montserrat E, Alcalá A, Parody R, Domingo A, García-Conde J, Bueno J, Ferrán C, Sanz MA, Giralt M, Rubio D. Cancer; 1985 Nov 15; 56(10):2369-75. PubMed ID: 3899346 [Abstract] [Full Text] [Related]
55. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial. Anderson J, Krivit W, Chilcote R, Pyesmany A, Chard R, Hammond D. Cancer Treat Rep; 1981 Nov 15; 65(11-12):1015-9. PubMed ID: 6945911 [Abstract] [Full Text] [Related]
56. Use of a vascular access system for administration of chemotherapeutic agents to a ferret with lymphoma. Rassnick KM, Gould WJ, Flanders JA. J Am Vet Med Assoc; 1995 Feb 15; 206(4):500-4. PubMed ID: 7768701 [Abstract] [Full Text] [Related]
57. VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia. Rivera G, Bowman WP, Murphy SB, Dahl GV, Aur RJ, Kalwinsky DK, Wood A, Stagner S, Avery TL. Med Pediatr Oncol; 1982 Feb 15; 10(5):439-46. PubMed ID: 6958957 [Abstract] [Full Text] [Related]
58. Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine. Lambertenghi-Deliliers G, Maiolo AT, Annaloro C, Pogliani E, Baldini L, Polli E. Cancer; 1984 Jul 15; 54(2):199-201. PubMed ID: 6586276 [Abstract] [Full Text] [Related]
59. Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group. van der Does-van den Berg A, van Wering ER, de Koning J, Rammeloo JA, Solbu G, Suciu S, van Zanen GE. Haematol Blood Transfus; 1987 Jul 15; 30():444-7. PubMed ID: 3305211 [No Abstract] [Full Text] [Related]
60. ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis. Martinelli G, Cocorocchio E, Peccatori F, Zucca E, Saletti PC, Calabrese L, Pastano R, Pruneri G, Mazzetta C, Ghielmini M, Cavalli F. Br J Haematol; 2004 Jun 15; 125(5):584-9. PubMed ID: 15147373 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]